Greg Everson
- Hepatology top 1%
- Hepatitis C virus research 9
- Liver Disease and Transplantation 5
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments 3
- Epidemiology top 10%
- Hepatitis B Virus Studies 4
- Liver Disease Diagnosis and Treatment 3
- Surgery top 10%
- Organ Transplantation Techniques and Outcomes 5
-
- Systemic Lupus Erythematosus Research 5
-
- Immunodeficiency and Autoimmune Disorders 4
Greg Everson
23 papers receiving 724 citations
Peers
Comparison fields: 5 of 51
- Hepatology 558
- Transplantation 163
- Epidemiology 347
- Surgery 361
- Rheumatology 39
Countries citing papers authored by Greg Everson
This map shows the geographic impact of Greg Everson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Everson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Everson more than expected).
Fields of papers citing papers by Greg Everson
This network shows the impact of papers produced by Greg Everson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Everson. The network helps show where Greg Everson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Greg Everson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 18 | |
| 2 | 2016 | 1 | |
| 3 | 2014 | 45 | |
| 4 | 2014 | 72 | |
| 5 | 2013 | 12 | |
| 6 | 2012 | 101 | |
| 7 | 2012 | 19 | |
| 8 | 2012 | 3 | |
| 9 | 2012 | 16 | |
| 10 | 2011 | 1 | |
| 11 | 2010 | 11 | |
| 12 | 2008 | 23 | |
| 13 | 2006 | 59 | |
| 14 | 2000 | 3 | |
| 15 | 1997 | 109 | |
| 16 | 1997 | 15 | |
| 17 | 1996 | 4 | |
| 18 | Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. | 1995 | 135 |
| 19 | Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection. | 1995 | 35 |
| 20 | 1993 | 4 |
About Greg Everson
Greg Everson is a scholar working on Hepatology, Transplantation, Rheumatology, Immunology and Genetics, having authored 23 papers that have together received 740 indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), Liver Disease and Transplantation (5 papers), Organ Transplantation Techniques and Outcomes (5 papers), Systemic Lupus Erythematosus Research (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Hepatitis B Virus Studies (4 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (558 citations), Transplantation (163 citations), Epidemiology (347 citations), Surgery (361 citations) and Rheumatology (39 citations). Greg Everson has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Mark D. Stegall, G Schröter, Frederick M. Karrer, Igal Kam, Bahri M. Bilir, Chris E. Freise, Robert A. Fisher, Michael Wachs, Anna S. Lok and F Karrer. Their work appears in journals such as Journal of Hepatology, Hepatology, The American Journal of Gastroenterology, Transplantation and European Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.